Stocklytics Platform
Asset logo for symbol SGRY
Surgery Partners
SGRY55
$22.82arrow_drop_up0.79%$0.17
Asset logo for symbol SGRY
SGRY55

$22.82

arrow_drop_up0.79%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Surgery Partners (SGRY) Stocklytics Forecast

According to analysts, Surgery Partners Inc (SGRY) has a positive stock price forecast for the next few years. The current stock price prediction suggests that SGRY could experience growth in the coming years. In particular, the stock price forecast for 2023 shows potential for an increase. This prediction is based on various factors, including the company's financial performance, market trends, and industry outlook.
Artificial intelligence (AI) and machine learning (ML) predictions also support the positive stock price forecast for SGRY. These advanced technologies analyze data and patterns to make accurate predictions. AI and ML algorithms consider various variables, such as historical stock performance, market trends, and company financials, to provide reliable forecasts. Their predictions are based on complex models that take into account numerous factors.
add Surgery Partners to watchlist

Keep an eye on Surgery Partners

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Surgery Partners (SGRY) stock?

Analysts have set a target price of $50.79 for Surgery Partners (SGRY), based on forecasts from 29 analysts. The predicted price range extends from a high of $65 to a low of $35. This represents a potential increase of up to 184.79% and a decrease of 53.35% from the current price of $22.82. These forecasts are as of 2021 Dec 03.
help

What are the analyst ratings for Surgery Partners (SGRY) stock?

Currently, there are no analyst ratings available for Surgery Partners (SGRY), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Surgery Partners (SGRY) stock?

At present, there is no AI or machine-learning-based price prediction available for Surgery Partners (SGRY) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level